![](/img/cover-not-exists.png)
3119 P53 disruptive mutation is a negative predictive factor in EGFR M+ NSCLC treated with TKI
Lüers, A., Neemann, N., Prenzel, R., Scriba, D., Willborn, K., Stropiep, U., Falk, M., Hallas, C., Tiemann, M., Griesinger, F.Volume:
51
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/s0959-8049(16)31760-9
Date:
September, 2015
File:
PDF, 64 KB
english, 2015